Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vergunst, H."" wg kryterium: Autor


Tytuł :
Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer.
Autorzy :
Exterkate L; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Peters M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Vergunst H; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
BJU international [BJU Int] 2020 Oct 11. Date of Electronic Publication: 2020 Oct 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Autorzy :
Hamoen EHJ; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hoeks CMA; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Vergunst H; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Oddens JR; Department of Urology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
Smits GA; Department of Urology, Alysis Zorggroep, Arnhem, The Netherlands.
Bokhorst LP; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Witjes JA; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Rovers MM; Department of Operating Rooms, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Health Evidence, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Barentsz JO; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology focus [Eur Urol Focus] 2019 May; Vol. 5 (3), pp. 407-415. Date of Electronic Publication: 2018 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biopsy/*methods
Magnetic Resonance Imaging, Interventional/*methods
Multiparametric Magnetic Resonance Imaging/*methods
Prostate/*pathology
Prostatic Neoplasms/*pathology
Watchful Waiting/*methods
Aged ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/diagnostic imaging
Czasopismo naukowe
Tytuł :
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Autorzy :
Van Neste L; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
Hendriks RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dijkstra S; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Trooskens G; MDxHealth BV, Nijmegen, The Netherlands.
Cornel EB; Department of Urology, ZGT Hospital, Hengelo, The Netherlands.
Jannink SA; MDxHealth BV, Nijmegen, The Netherlands.
de Jong H; MDxHealth BV, Nijmegen, The Netherlands.
Hessels D; MDxHealth BV, Nijmegen, The Netherlands.
Smit FP; MDxHealth BV, Nijmegen, The Netherlands.
Melchers WJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Leyten GH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands.
de Reijke TM; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands.
Vergunst H; Department of Urology, CWZ Hospital, Nijmegen, The Netherlands.
Kil P; Department of Urology, St. Elisabeth Hospital, Tilburg, The Netherlands.
Knipscheer BC; Department of Urology, Scheper Hospital, Emmen, The Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mulders PF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Van Criekinge W; Department of Mathematical Modelling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium.
Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2016 Nov; Vol. 70 (5), pp. 740-748. Date of Electronic Publication: 2016 Apr 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/urine
RNA, Messenger*/analysis
RNA, Messenger*/urine
Homeodomain Proteins/*genetics
Medical Overuse/*prevention & control
Transcription Factors/*genetics
Aged ; Biomarkers, Tumor/genetics ; Clinical Decision-Making/methods ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Patient Selection ; Prostate/pathology ; Prostate-Specific Antigen/analysis ; Reproducibility of Results ; Research Design ; Risk Assessment/methods ; Risk Factors
Czasopismo naukowe
Tytuł :
The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis.
Autorzy :
Dijkstra S; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Witjes WP; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Roos EP; Department of Urology, Antonius Hospital, Bolswarderbaan 1, P.O. Box 20.000, 8600 BA Sneek, The Netherlands.
Vijverberg PL; Department of Urology, St. Antonius Hospital, Koekoekslaan 1, P.O. Box 2500, 3435 CM Nieuwegein, The Netherlands.
Geboers AD; Department of Urology, Slingeland Hospital, Kruisbergseweg 25, P.O. Box 169, 7000 AD Doetinchem, The Netherlands.
Bruins JL; Department of Urology, Koningin Beatrix Hospital, Beatrixpark 1, P.O. Box 9005, 7100 GG Winterswijk, The Netherlands.
Smits GA; Department of Urology, Rijnstate Hospital, Wagnerlaan 55, P.O. Box 9555, 6800 TA Arnhem, The Netherlands.
Vergunst H; Department of Urology, Canisius Wilhelmina Hospital, Weg Door Jonkerbos 100, P.O. Box 9015, 6532 SZ Nijmegen, The Netherlands.
Mulders PF; Department of Urology, Radboud University Medical Center, Geert Grooteplein Zuid 10, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
SpringerPlus [Springerplus] 2016 May 17; Vol. 5, pp. 653. Date of Electronic Publication: 2016 May 17 (Print Publication: 2016).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial.
Autorzy :
van Tol-Geerdink JJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Leer JW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Wijburg CJ; Department of Urology, Rijnstate Hospital, Arnhem, the Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Vergunst H; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
van Lin EJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Stalmeier PF; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
Pokaż więcej
Źródło :
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2016 Apr; Vol. 19 (2), pp. 459-70. Date of Electronic Publication: 2015 May 03.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Decision Support Techniques*
Emotions*
Patient Participation/*psychology
Prostatic Neoplasms/*therapy
Aged ; Analysis of Variance ; Choice Behavior ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/psychology ; Quality of Life
Czasopismo naukowe
Tytuł :
383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer
Autorzy :
Hendriks, R.J.
Dijkstra, S.
Trooskens, G.
Van Criekinge, W.
Cornel, E.B.
Jannink, S.A.
De Jong, H.
Hessels, D.
Smit, F.P.
Melchers, W.J.G.
Leyten, G.H.J.M.
De Reijke, T.M.
Vergunst, H.
Kil, P.
Knipscheer, B.C.
Hulsbergen-Van De Kaa, C.A.
Mulders, P.F.A.
Van Oort, I.M.
Van Neste, L.
Schalken, J.A.
Pokaż więcej
Źródło :
In European Urology Supplements March 2016 15(3):e383-e383
Czasopismo naukowe
Tytuł :
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.
Autorzy :
Leyten GH; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
Hessels D; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Smit FP; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Jannink SA; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
de Jong H; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Melchers WJ; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Cornel EB; ZGT Hospital, Department of Urology, Hengelo, the Netherlands.
de Reijke TM; AMC University Medical Centre, Department of Urology, Amsterdam, the Netherlands.
Vergunst H; CWZ Hospital, Department of Urology, Nijmegen, the Netherlands.
Kil P; St Elisabeth Hospital, Department of Urology, Tilburg, the Netherlands.
Knipscheer BC; Scheper Hospital, Department of Urology, Emmen, the Netherlands.
Hulsbergen-van de Kaa CA; Radboud University Nijmegen Medical Centre, Department of Pathology, Nijmegen, the Netherlands.
Mulders PF; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
van Oort IM; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
Schalken JA; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands. .
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Jul 01; Vol. 21 (13), pp. 3061-70. Date of Electronic Publication: 2015 Mar 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*urine
Prostatic Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Carrier Proteins/genetics ; Carrier Proteins/urine ; Cell Cycle Proteins ; Early Detection of Cancer ; Homeodomain Proteins/genetics ; Homeodomain Proteins/urine ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/urine ; Quinolines ; ROC Curve ; Transcription Factors/genetics ; Transcription Factors/urine ; Transcriptome
Czasopismo naukowe
Tytuł :
Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer.
Autorzy :
Arends TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lammers RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Falke J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Rustighini I; Telormedix SA, Bioggio, Switzerland.
Pozzi R; Telormedix SA, Bioggio, Switzerland.
Ravic M; Pharma Integra Ltd, Wimbledon, London, England, UK.
Eisenhardt A; Pur/r Praxisklinik Urologie, Nordrhein-Westfalen, Germany.
Vergunst H; Department of Urology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2015 Jun; Vol. 13 (3), pp. 204-9.e2. Date of Electronic Publication: 2014 Dec 31.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms :
Aminoquinolines/*administration & dosage
Antineoplastic Agents/*administration & dosage
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Administration, Intravesical ; Aminoquinolines/adverse effects ; Aminoquinolines/pharmacokinetics ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/surgery ; Cystoscopy ; Dose-Response Relationship, Drug ; Female ; Humans ; Imiquimod ; Interleukin 1 Receptor Antagonist Protein/urine ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies